Linking antimicrobial prescribing to antimicrobial resistance in the ICU: Before and after an antimicrobial stewardship program

Epidemics

Volumn 4, Issue 4, 2012, Pages 203-210

  Hurford, Amy ^a,b,c   Morris, Andrew M ^d,e   Fisman, David N ^b   Wu, Jianhong ^c  

^a FIELDS INSTITUTE   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c YORK UNIVERSITY   (Canada)

^d MOUNT SINAI HOSPITAL   (Canada)

^e UNIVERSITY OF TORONTO   (Canada)

Author keywords

Antibiotic resistance; Antimicrobial stewardship; Inappropriate prescribing; Mathematical model; Pseudomonas aeruginosa

Indexed keywords

CEFTAZIDIME; CIPROFLOXACIN; MEROPENEM; PIPERACILLIN PLUS TAZOBACTAM; TOBRAMYCIN;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ANTIBIOTIC THERAPY; ARTICLE; BACTERIAL COLONIZATION; BACTERIUM ISOLATE; HUMAN; INTENSIVE CARE; MATHEMATICAL MODEL; NONHUMAN; PRESCRIPTION; PRIORITY JOURNAL; PSEUDOMONAS INFECTION; TREATMENT DURATION;

ANTI-BACTERIAL AGENTS; DRUG PRESCRIPTIONS; DRUG RESISTANCE, BACTERIAL; HUMANS; INTENSIVE CARE UNITS; MATHEMATICAL COMPUTING; MICROBIAL SENSITIVITY TESTS; MODELS, THEORETICAL; ONTARIO; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTIONS;

EID: 84872236817     PISSN: 17554365     EISSN: 18780067     Source Type: Journal    
DOI: 10.1016/j.epidem.2012.12.001     Document Type: Article

References (30)

1. Ansari F., Kirsteen G., Nathwani D., Phillips G., Ogston S., Ramsay C., Davey P. Outcomes of an intervention to improve hospital antimicrobial prescribing: interrupted time series with segmented regression analysis. Journal of Antimicrobial Chemotherapy 2003, 52:842-848.
2. Austin D.J., Kristinsson K.G., Anderson R.M. The relationship between the volume of antimicrobial consumption in human communities and the frequency of resistance. Proceedings of the National Academy of Sciences of the United States of America 1999, 96:1152-1156.
3. Boldin B., Bonten M.J.M., Diekmann O. Relative effects of barrier precautions and topical antibiotics on nosocomial bacterial transmission: results of multi-compartment models. Bulletin of Mathematical Biology 2007, 69:2227-2248.
4. Bonhoeffer S., Lipsitch M., Levin B.R. Evaluating treatment protocols to prevent antibiotic resistance. Proceedings of the National Academy of Sciences of the United States of America 1997, 94:12106-12111.
5. Bonten M.J.M., Bergmanns D.C.J.J., Speijer H., Stobberingh E.E. Characteristics of polyclonal endemicity of Pseudomonas aeruginosa colonization in intensive care units. American Journal of Respiratory and Critical Care Medicine 1999, 160:1212-1219.
6. Bootsma M.C.J., Diekmann O., Bonten M.J.M. Controlling methicillin-resistant Staphylococcus aureus: quantifying the effects of interventions and rapid diagnostic testing. Proceedings of the National Academy of Sciences of the United States of America 2006, 103:5620-5625.
7. Boyer A., Doussau A., Thièbault R., Venier A.G., Tran V., Boulestreau H. Pseudomonas aeruginosa acquisition in an intensive care unit: relationship between antibiotic selective pressure and patients' environment. Critical Care 2011, 15:R55.
8. Cardo D., Horan T., Andrus M., Dembinski M., Edwards J., Peavy G., Tolson J., Wagner D. National Nosocomial Infections Surveillance (NNIS) system report, data summary from January 1992 through June 2004, issued October 2004. American Journal of Infection Control 2004, 32:470-485.
9. Centers for Medicare & Medicaid Services (CMS) Medicare program; hospital inpatient value-based purchasing program. Final rule. Federal Register 2011, 76:26490-26547.
10. D'Agata E.M., Webb G.F., Horn M.A., Moellering R.C., Ruan S. Modeling the invasion of community-acquired methicillin-resistant Staphylococcus aureus in the hospital setting. Clinical Infectious Diseases 2009, 48:274-284.
11. Dellit T.H., Owens R.C., McGowan J.E., Gerding D.N., Weinstein R.A., Burke J.P., Huskins W.C., Paterson D.L. Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America guidelines for developing an institutional program to enhance antimicrobial stewardship. Clinical Infectious Diseases 2007, 44:159-177.
12. Gustafsson I., Martínez J.L. Crosstalk between antibiotic resistance and virulence in Pseudomonas aeruginosa. Reviews in Medical Microbiology 2005, 16:155-161.
13. Jones R.N., Sader H.S., Moet G.J., Farrell D.J. Declining antimicrobial susceptibility of Streptococcus pneumoniae in the United States: report from the sentry antimicrobial surveillance program (1998-2009). Diagnostic Microbiology and Infectious Disease 2010, 68:334-336.
14. Jones R.N., Stillwell M.G., Rhomberg P.R., Sader H.S. Antipseudomonal activity of piperacillin/tazobactam: more than a decade of experience from the sentry antimicrobial surveillance program (1997-2007). Diagnostic Microbiology and Infectious Disease 2009, 65:331-334.
15. Juan C., Gutierrez O., Oliver A., Ayestaran J.I., Borrell N., Perez J.L. Contribution of clonal dissemination and selection of mutants during therapy to Pseudomonas aeruginosa antimicrobial resistance in an intensive care unit setting. Clinical Microbiology and Infection 2005, 11:887-892.
16. Kohn L.T., Corrigan J.M., Donaldson M.S. To Err Is Human: Building a Safer Health System 2000, The National Academies Press, Washington, D.C.
17. Lipsitch M., Bergstrom C.T., Levin B.R. The epidemiology of antibiotic resistance in hospitals: paradoxes and prescriptions. Proceedings of the National Academy of Sciences of the United States of America 2000, 97:1938-1943.
18. Oosdijk E.A.N., de Smet A.M.G.A., Blok H.E., Thieme Groen E.S., van Asselt G.J., Benus R.F.J., Bernards S.A.T. Ecological effects of selective decontamination on resistant gram-negative bacterial colonization. American Journal of Respiratory and Critical Care Medicine 2009, 181:451-457.
19. Paterson D.L., Rossi F., Baquero F., Hsueh P.R., Woods G.L., Satishchandran V., Snyder T.A., Harvey C.M., Teppler H., DiNubile M.J., Chow J.W. In vitro susceptibilities of aerobic and facultative gram-negative bacilli isolated from patients with intra-abdominal infections worldwide: the 2003 Study for Monitoring Antimicrobial Resistance Trends (SMART). Journal of Antimicrobial Chemotherapy 2005, 55:965-973.
20. Peto Z., Benko R., Matuz M., Csullog E., Molnar A., Hajdu E. Results of a local antibiotic management program on antimicrobial use in a tertiary intensive care unit in Hungary. Infection 2008, 36:560-564.
21. Safdar N., Maki D.G. The commonality of risk factors for nosocomial colonization and infection with antimicrobial-resistant Staphylococcus aureus, enterococcus, gram-negative bacilli, Clostridium difficile, and Candida. Annals of Internal Medicine 2002, 136:834-844.
22. Saidel-Odes L., Polachek H., Peled N., Riesenberg K., Schlaeffer F., Trabelsi Y. A randomized, double-blind, placebo-controlled trial of selective digestive decontamination using oral gentamicin and oral polymyxine for eradication of carbapenem-resistant Klebsiella pneumoniae carriage. Infection Control and Hospital Epidemiology 2012, 33:14-19.
23. Sandiumenge A., Diaz E., Rodriguez A., Vidaur L., Canadell L. Impact of diversity of antibiotic use on the development of antimicrobial resistance. Journal of Antimicrobial Chemotherapy 2006, 57:1197-1204.
24. Shlaes D.M., Gerding D.N., John J.F., Craig W.A., Bornstein D.L., Duncan R.A. Society for Healthcare Epidemiology of America and Infectious Diseases Society of America joint committee on the prevention of antimicrobial resistance: guidelines for the prevention of antimicrobial resistance in hospitals (reprinted from Infection Control and Hospital Epidemiology 18 (1997) 275-291). Clinical Infectious Diseases 1997, 25:584-599.
25. Smith D.L., Dushoff J., Perencevich E.N., Harris A.D., Levin S.A. Persistent colonization and the spread of antibiotic resistance in nosocomial pathogens: resistance is a regional problem. Proceedings of the National Academy of Sciences of the United States of America 2004, 101:3709-3714.
26. Sun H.Y., Fujitani S., Quintiliani R., Yu V.L. Pneumonia due to Pseudomonas aeruginosa. Part II. Antimicrobial resistance, pharmacodynamic concepts, and antibiotic therapy. Chest 2011, 139:1172-1185.
27. Thuong M., Arvaniti K., Ruimy R., de la Salmonière P., Scanvic-Hameg A., Lucet J.C., Règnier B. Epidemiology of Pseudomonas aeruginosa and risk factors for carriage acquisition in an intensive care unit. Journal of Hospital Infection 2003, 53:274-282.
28. Vincent J.L. Nosocomial infections in adult intensive-care units. Lancet 2003, 361:2068-2077.
29. Weber D.J., Raasch R., Rutala W.A. Nosocomial infections in the ICU - the growing importance of antibiotic-resistant pathogens. Chest 1999, 115:34S-41S.
30. Yong M.K., Buising K.L., Cheng A.C., Thursky K.A. Improved susceptibility of gram-negative bacteria in an intensive care unit following implementation of a computerized antibiotic decision support system. Journal of Antimicrobial Chemotherapy 2010, 65:1062-1069.